Danino et al. has investigated the anti-tumor activity of E. coli expressing both anti-PD-L1 and anti-CTLA-4 antibodies against advanced lymphoma in a mouse model with a larger initial volume (about 200 to 700 mm3), in which impaired growth or complete clearance was observed (67). This evidence concerns the gene CTLA4 and neoplasm.